Hormonal Preparations

Hormonal Preparations

 

medications that contain hormones or their synthetic analogs, used in hormone therapy.

Hormonal preparations may contain natural hormones (prepared from the fresh or fresh-frozen glands of slaughter cattle and from the blood and urine of animals and man), synthetic hormone preparations and their derivatives, or the synthetic analogs of hormones (which differ in chemical structure from natural hormones but exert the same physiological effects).

Hormonal preparations of the pituitary (ACTH, ACTH-zinc phosphate, chorionic gonadotropin, serum gonadotropin, prolactin, intermedin, Pituitrin, and adiurecrinum) and the synthetic pituitary hormonal preparations of oxytocin and vasopressin are used for hormonal deficiency of the pituitary, adrenals, and gonads, as well as in collagenoses, allergies, and certain eye diseases.

Thyroidin, the hormonal preparation of the thyroid, is used to treat deficiency of thyroid function, obesity, and neuroses. Parathyroidin, the hormonal preparation of the parathyroids (obtained from the parathyroid glands of slaughter cattle), is used to treat various forms of tetany, spasmophilia, and allergic diseases.

The hormonal preparations of the pancreas include insulin and its derivatives (for example, zinc insulin and zinc-protamine insulin), which lower the sugar content of the blood and are used to treat diabetes mellitus. Also used as sugar-reducing medications in diabetes are the synthetic substitutes for insulin—Butamide, cyclamide, and chlorproma-zine. Lipocaic, used in liver diseases and atherosclerosis, is also one of the pancreatic hormone preparations.

The adrenocortical hormonal preparations are cortisone, hydrocortisone, and desoxycorticosterone and the synthetic analogs of cortisone and hydrocortisone, including prednisolone, prednisone, dexamethasone, and synalar. They are used in the treatment of rheumatism, infectious polyarthritis, bronchial asthma, infectious mononucleosis, neurodermati-tides, eczemas and other skin diseases, Addison’s disease, acute hormonal insufficiency of the adrenal cortex, hemolytic anemia, glomerulonephritis, and acute pancreatitis.

Hormonal preparations of the female sex hormones are divided into the estrogenic hormone preparations (folliculin [estrone], estradiol monobenzoate, estradiol dipropionate, ethyl estradiol, Sinestrol, diethylstilbestrol, dimestrol, Oc-toestrolum, and Sygethinum) and the gestagenic preparations (progesterone, hydroxyprogesterone capronate, and preg-nene). Estrogenic preparations are used in functional deficiency or complete absence of ovarian endocrine activity and in weak partial activity and cessation of lactation, as well as in treating cancer of the prostate gland in men. Gestagenic hormonal preparations are used in disturbances connected with deficiency of the corpus luteum.

Preparations of male sex hormones, or androgenic preparations (testosterone propionate, testosterone enanthate, methyltestosterone) possess the biological and therapeutic properties of the hormone testosterone, which is manufactured in the male gonads. The preparations are used in male gonadal deficiency, during the climacteric in both men and women, in vascular and nervous disturbances, and in acromegaly.

Hormonal preparations are used both in water or oil solution for subcutaneous and intramuscular injection and in the form of tablets and ointments. The specific activity of a hormonal preparation from animal stock is established by comparison with the activity of standard preparations (biological standardization) and is expressed in activity units (AU).

REFERENCES

Mashkovskii, M. D. Lekarstvennye sredstva, 6th ed., vol 1. Moscow, 1967.
Milku, Sh. Terapiia endokrinnykh zabolevanii, vol. 2. Bucharest, 1962. [Translated from Rumanian.]

P. A. SHAROV

References in periodicals archive ?
Hormonal preparations for systemic use excluding sex hormones and insulins;6.
Therefore, improvement of traditional technologies of receiving hormonal preparations for the purpose of development of new methods of production of domestic hormonal preparations for the accelerated reproduction and increase in production of agricultural animals, is a topical issue [10, 11].
emergency contraceptive pills, herbal medicines, hormonal preparations or the combination of methylestrenolone and methylestradiol) and 46% offered both.
It is possible to use special hormonal preparations, which reduce testosterone in blood.
While a quiet debate has persisted for decades as to whether oral contraceptives should be made available without a prescription, safety concerns have made such a move unlikely But safety issues associated with long-term use of hormonal preparations do not exist with the two currently available emergency contraceptive products Preven (levonorgestrel and ethinyl estradiol) and Plan B (levonorgestrel), Dr.
Contract award: Systemic hormonal preparations, excl.
Medicinal products obstructive airways disease; various drugs; medicines for blood and blood-forming organs; Solution for parenteral nutrition; Enteral nutrition products; antibiotics and chemotherapeutics for dermatological use; corticosteroids for dermatological use and dermatological preparations; Medical solutions; beta-blockers; antivirals for systemic use; ophthalmic drugs; diabetes medications; oral contraceptives; Systemic hormonal preparations, excluding sex hormones.
Therapy area analysis: Systemic hormonal preparations
Invitation to tender: drugs group h systemic hormonal preparations with the exception of sex-somatropin
Procurement Medicinal Products for Obstructive Airway Diseases; Various Drugs; Drugs for Blood and Blood-Forming Organs; Solution for Parenteral Nutrition; Enteral Nutrition Products; Antibiotics and Chemotherapeutics for Dermatological Use; Corticosteroids for Dermatological Use and Dermatological Preparations; Medical Solutions; Beta-Blockers; Antivirals for Systemic Use; Ophthalmologicals; Medicines for Diabetes; Oral Contraceptives; Systemic Hormonal Preparations, Excluding Sex Hormones
Contract notice: Systemic hormonal preparations, excl.
Use of hormonal preparations within 1 month prior to randomization (patients may not take OCP's in cycle prior to stimulation cycle)